Fact CheckerSign in

NCT06591130Completed

Culturally Adapted Intervention to Prevent Self-harm in Young People With Autism

A Pilot Trial of a Culturally Adapted Intervention to Prevent Self-harm in Young People With Autism

Source: ClinicalTrials.gov · Last updated 1 Jul 2026

Brief summary (registry, in English)

The goal of this feasibility randomized controlled trial is to assess the feasibility and acceptability of Youth Culturally Adapted Manually Assisted brief psychological intervention (YCMAP) in young people with autism in Pakistan. In a rater-blind, 2-arm, multi-site, feasibility randomized controlled trial (RCT), participants will be randomized either to 1) YCMAP added to the Treatment as Usual (TAU) or 2) TAU alone. Participants in the Y-CMAP arm will receive 8-10 sessions delivered individually over 3 months (weekly for 1 month then fortnightly), lasting for 60 minutes. Assessments will be conducted at baseline and at 3 months.

Status (registry)
Completed
Study type
Interventional
Enrollment
80 (actual)
First submitted
16 Aug 2024
Start date
1 Oct 2024
Primary completion date
15 Feb 2026
Lead sponsor
Pakistan Institute of Living and Learning
Diseases
Autism
NCT number
NCT06591130

What you commit to

  • Study type: Interventional
  • Participants enrolled: 80
  • From 1 Oct 2024 to the primary completion date, 15 Feb 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • With any chronic medical disorder or physical condition (including communicable diseases such as Tuberculosis) that would prevent participation in assessments and or intervention.

Other

  • Young people with autism with limited receptive and expressive language skills that would prevent engagement
  • Not willing to participate.

Who the study is looking for

  • Aged 14-24 years
  • History of self-harm and/or possible suicidal behavior
  • Able to engage in assessment and intervention
  • Ability to provide informed consent

Age in the registry: 14 years to 24 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Pakistan Centre for Autism
Coordinator of this site? Confirm its status
KarachiPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.